Editing AUA: Urethral Stricture Disease (2023) (section)

===Post-operative follow-up===
*'''<span style="color:#ff0000">Following dilation, DVIU or urethroplasty for urethral stricture, patients should be monitored to identify symptomatic recurrence'''
**'''Successful treatment for urethral stricture (endoscopic or surgical) is most commonly defined as no further need for surgical intervention or instrumentation.'''
***Other descriptions for successful treatment:
****Absence of postoperative or post-procedural patient reported obstructive voiding symptoms
****Patient-reported improvement in LUTS
****Peak uroflow >15m/sec
****PVR urine <100mL
****"Unobstructed" flow curve shape on uroflowmetry
****Absence of UTI
****Ability to pass a urethral catheter
**Consider more frequent follow-up intervals in '''males at an increased risk for stricture recurrence (7):'''
**#'''Prior failed treatment (multiple endoscopic procedures or previous urethroplasty)'''
**#'''Long stricture'''
**#'''Repair involving a flap or graft'''
**#'''LS-related stricture'''
**#'''Hypospadias-related stricture'''
**#'''Smoking''' (tobacco use)
**#'''Diabetes'''
*Urethral Stents
**Although stents are not currently recommended for the treatment of urethral stricture, patients treated with a urethral stent after dilation or internal urethrotomy should be monitored for recurrent stricture and complications as these can occur at any time point after stent placement.
**Patients with completely obstructed stents may require open urethroplasty and removal of the stent.
**'''Stents do not need to be prophylactically removed and should be followed conservatively unless associated with significant urethral or voiding symptoms.'''